title: Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy.
authors.affiliation: Birmingham and Midland Eye Centre, Birmingham, UK.
authors.forename: Ambreen
authors.initials: A
authors.lastname: Sarmad
authors.affiliation: Birmingham and Midland Eye Centre, Birmingham, UK.
authors.forename: Peck Lin
authors.initials: PL
authors.lastname: Lip
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D001794:Blood Pressure; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003930:Diabetic Retinopathy / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation; D008269:Macular Edema / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D006442:Glycated Hemoglobin; D042461:Vascular Endothelial Growth Factor A; C467484:VEGFA protein, human; C517652:hemoglobin A1c protein, human